| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Taxes | 24 | 2023 | 73 | 5.880 |
Why?
|
| Noncommunicable Diseases | 12 | 2022 | 77 | 4.940 |
Why?
|
| Health Priorities | 13 | 2023 | 62 | 4.680 |
Why?
|
| Humans | 140 | 2025 | 14537 | 3.910 |
Why?
|
| Beverages | 15 | 2021 | 42 | 3.870 |
Why?
|
| South Africa | 84 | 2025 | 7596 | 3.600 |
Why?
|
| Cost-Benefit Analysis | 20 | 2024 | 253 | 3.270 |
Why?
|
| Health Promotion | 10 | 2023 | 109 | 3.080 |
Why?
|
| Obesity | 15 | 2023 | 367 | 3.030 |
Why?
|
| Global Health | 10 | 2021 | 193 | 2.480 |
Why?
|
| Technology Assessment, Biomedical | 6 | 2023 | 11 | 2.440 |
Why?
|
| Health Care Costs | 8 | 2022 | 115 | 2.300 |
Why?
|
| Public Health | 11 | 2020 | 124 | 2.130 |
Why?
|
| Dietary Sucrose | 6 | 2017 | 17 | 2.100 |
Why?
|
| Maternal Health Services | 4 | 2023 | 52 | 2.040 |
Why?
|
| Health Policy | 8 | 2023 | 140 | 1.980 |
Why?
|
| Child Health Services | 4 | 2020 | 35 | 1.930 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 71 | 1.930 |
Why?
|
| Delivery of Health Care | 9 | 2024 | 239 | 1.930 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 104 | 1.890 |
Why?
|
| Pandemics | 8 | 2025 | 296 | 1.820 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2020 | 139 | 1.760 |
Why?
|
| Sweetening Agents | 4 | 2021 | 10 | 1.740 |
Why?
|
| Measles | 4 | 2023 | 36 | 1.710 |
Why?
|
| Child | 33 | 2024 | 2242 | 1.680 |
Why?
|
| Stroke | 4 | 2022 | 62 | 1.610 |
Why?
|
| Developing Countries | 12 | 2020 | 400 | 1.610 |
Why?
|
| Carbonated Beverages | 4 | 2021 | 9 | 1.520 |
Why?
|
| Diet | 5 | 2023 | 109 | 1.510 |
Why?
|
| Family Planning Services | 5 | 2019 | 46 | 1.490 |
Why?
|
| Female | 48 | 2024 | 9103 | 1.420 |
Why?
|
| Hypertension | 5 | 2025 | 419 | 1.410 |
Why?
|
| Schools | 6 | 2023 | 73 | 1.380 |
Why?
|
| Cost of Illness | 8 | 2022 | 167 | 1.330 |
Why?
|
| National Health Programs | 5 | 2021 | 78 | 1.290 |
Why?
|
| Biomedical Research | 4 | 2017 | 49 | 1.240 |
Why?
|
| Adult | 29 | 2024 | 5913 | 1.200 |
Why?
|
| Male | 37 | 2024 | 6754 | 1.200 |
Why?
|
| Food Industry | 5 | 2020 | 11 | 1.190 |
Why?
|
| International Cooperation | 5 | 2020 | 50 | 1.160 |
Why?
|
| Public Sector | 4 | 2021 | 82 | 1.160 |
Why?
|
| Rural Population | 6 | 2025 | 654 | 1.110 |
Why?
|
| Capacity Building | 3 | 2019 | 32 | 1.100 |
Why?
|
| Measles Vaccine | 5 | 2020 | 34 | 1.100 |
Why?
|
| Diabetes Mellitus | 4 | 2025 | 146 | 1.090 |
Why?
|
| Health Services Accessibility | 6 | 2023 | 280 | 1.080 |
Why?
|
| Research | 6 | 2022 | 65 | 1.050 |
Why?
|
| Bibliometrics | 3 | 2016 | 5 | 1.050 |
Why?
|
| Contraception | 2 | 2019 | 90 | 1.020 |
Why?
|
| Child Mortality | 6 | 2017 | 96 | 1.000 |
Why?
|
| Nutrition Policy | 4 | 2021 | 19 | 0.990 |
Why?
|
| Middle Aged | 20 | 2023 | 3601 | 0.980 |
Why?
|
| Primary Prevention | 2 | 2017 | 27 | 0.970 |
Why?
|
| Costs and Cost Analysis | 5 | 2017 | 42 | 0.970 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 26 | 0.960 |
Why?
|
| Consumer Behavior | 4 | 2021 | 20 | 0.950 |
Why?
|
| Mobile Health Units | 2 | 2016 | 7 | 0.930 |
Why?
|
| Maternal-Child Health Services | 2 | 2016 | 11 | 0.920 |
Why?
|
| Nutritional Status | 3 | 2023 | 76 | 0.910 |
Why?
|
| Mortality | 2 | 2017 | 104 | 0.910 |
Why?
|
| Child Health | 4 | 2023 | 77 | 0.900 |
Why?
|
| Maternal Death | 2 | 2015 | 25 | 0.890 |
Why?
|
| Stillbirth | 2 | 2016 | 83 | 0.890 |
Why?
|
| Immunization Programs | 4 | 2020 | 81 | 0.880 |
Why?
|
| Community Health Workers | 2 | 2017 | 66 | 0.870 |
Why?
|
| Mothers | 6 | 2024 | 195 | 0.870 |
Why?
|
| Aged | 14 | 2021 | 1740 | 0.860 |
Why?
|
| Adolescent | 22 | 2024 | 2985 | 0.860 |
Why?
|
| Chronic Disease | 4 | 2025 | 107 | 0.860 |
Why?
|
| Mental Health Services | 2 | 2014 | 10 | 0.840 |
Why?
|
| Policy | 6 | 2023 | 42 | 0.840 |
Why?
|
| Sugars | 4 | 2023 | 14 | 0.840 |
Why?
|
| Diabetic Retinopathy | 2 | 2014 | 5 | 0.830 |
Why?
|
| Overweight | 2 | 2022 | 87 | 0.820 |
Why?
|
| Health Equity | 1 | 2023 | 12 | 0.790 |
Why?
|
| Nutritive Value | 2 | 2020 | 4 | 0.770 |
Why?
|
| Resource Allocation | 2 | 2023 | 16 | 0.740 |
Why?
|
| Socioeconomic Factors | 8 | 2021 | 411 | 0.730 |
Why?
|
| Prevalence | 9 | 2019 | 1192 | 0.730 |
Why?
|
| Health Care Rationing | 3 | 2019 | 16 | 0.720 |
Why?
|
| Pregnancy | 13 | 2024 | 1862 | 0.720 |
Why?
|
| Politics | 2 | 2021 | 24 | 0.710 |
Why?
|
| Prenatal Care | 3 | 2023 | 147 | 0.710 |
Why?
|
| Contraception Behavior | 2 | 2019 | 54 | 0.710 |
Why?
|
| Infant | 15 | 2023 | 2244 | 0.700 |
Why?
|
| Poverty | 4 | 2023 | 152 | 0.700 |
Why?
|
| Health Resources | 4 | 2019 | 66 | 0.680 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 69 | 0.680 |
Why?
|
| Namibia | 4 | 2021 | 19 | 0.680 |
Why?
|
| Rwanda | 4 | 2021 | 30 | 0.680 |
Why?
|
| Health Expenditures | 3 | 2024 | 39 | 0.670 |
Why?
|
| Policy Making | 4 | 2021 | 32 | 0.660 |
Why?
|
| Health Services Needs and Demand | 3 | 2015 | 57 | 0.660 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2020 | 19 | 0.650 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 43 | 0.650 |
Why?
|
| Uganda | 4 | 2021 | 197 | 0.650 |
Why?
|
| Ethics, Medical | 1 | 2020 | 11 | 0.650 |
Why?
|
| Kenya | 4 | 2021 | 183 | 0.650 |
Why?
|
| Tanzania | 4 | 2021 | 88 | 0.650 |
Why?
|
| Budgets | 1 | 2020 | 12 | 0.640 |
Why?
|
| Coronavirus | 1 | 2020 | 14 | 0.640 |
Why?
|
| Dietary Sugars | 2 | 2020 | 7 | 0.640 |
Why?
|
| Violence | 1 | 2020 | 68 | 0.620 |
Why?
|
| Drugs, Essential | 1 | 2019 | 4 | 0.620 |
Why?
|
| Food Supply | 3 | 2020 | 29 | 0.620 |
Why?
|
| Contraceptive Agents | 1 | 2019 | 27 | 0.610 |
Why?
|
| Infant Food | 1 | 2019 | 4 | 0.600 |
Why?
|
| Infant Nutrition Disorders | 1 | 2019 | 4 | 0.600 |
Why?
|
| Research Personnel | 3 | 2015 | 19 | 0.590 |
Why?
|
| Young Adult | 11 | 2024 | 2498 | 0.590 |
Why?
|
| Zambia | 5 | 2021 | 115 | 0.570 |
Why?
|
| Periodicals as Topic | 3 | 2009 | 8 | 0.570 |
Why?
|
| Private Sector | 2 | 2015 | 45 | 0.560 |
Why?
|
| Models, Economic | 2 | 2014 | 15 | 0.540 |
Why?
|
| Child, Preschool | 11 | 2021 | 1748 | 0.540 |
Why?
|
| Surgical Procedures, Operative | 1 | 2017 | 8 | 0.540 |
Why?
|
| Preventive Health Services | 2 | 2014 | 17 | 0.540 |
Why?
|
| Pregnancy Complications | 2 | 2015 | 55 | 0.530 |
Why?
|
| Quality Assurance, Health Care | 1 | 2017 | 43 | 0.530 |
Why?
|
| Workers' Compensation | 1 | 2017 | 5 | 0.530 |
Why?
|
| Energy Drinks | 1 | 2017 | 3 | 0.530 |
Why?
|
| Fiscal Policy | 1 | 2017 | 3 | 0.530 |
Why?
|
| Television | 1 | 2017 | 7 | 0.530 |
Why?
|
| Marketing | 1 | 2017 | 6 | 0.520 |
Why?
|
| Occupational Health | 1 | 2017 | 24 | 0.520 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 127 | 0.510 |
Why?
|
| Dental Care | 1 | 2016 | 1 | 0.510 |
Why?
|
| Mental Disorders | 2 | 2014 | 44 | 0.510 |
Why?
|
| Botswana | 3 | 2021 | 24 | 0.510 |
Why?
|
| Healthcare Financing | 1 | 2016 | 5 | 0.500 |
Why?
|
| Sports | 1 | 2017 | 43 | 0.500 |
Why?
|
| Epilepsy, Generalized | 1 | 2016 | 3 | 0.500 |
Why?
|
| Mortality, Premature | 1 | 2016 | 6 | 0.490 |
Why?
|
| Mental Health | 3 | 2022 | 91 | 0.490 |
Why?
|
| Ambulatory Care | 1 | 2016 | 54 | 0.480 |
Why?
|
| Disabled Persons | 2 | 2013 | 23 | 0.480 |
Why?
|
| Food | 3 | 2023 | 11 | 0.470 |
Why?
|
| Environment | 1 | 2015 | 22 | 0.470 |
Why?
|
| Women, Working | 1 | 2015 | 3 | 0.470 |
Why?
|
| Africa South of the Sahara | 5 | 2021 | 353 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2025 | 256 | 0.460 |
Why?
|
| Infant Mortality | 4 | 2017 | 97 | 0.460 |
Why?
|
| Patient Education as Topic | 3 | 2014 | 48 | 0.450 |
Why?
|
| Food Labeling | 1 | 2015 | 3 | 0.450 |
Why?
|
| Perinatal Care | 1 | 2015 | 21 | 0.450 |
Why?
|
| Perinatal Death | 1 | 2015 | 33 | 0.440 |
Why?
|
| Capitation Fee | 1 | 2014 | 2 | 0.440 |
Why?
|
| Economic Development | 1 | 2014 | 5 | 0.430 |
Why?
|
| Blindness | 1 | 2014 | 2 | 0.430 |
Why?
|
| Vision Screening | 1 | 2014 | 3 | 0.430 |
Why?
|
| Diarrhea | 1 | 2015 | 76 | 0.430 |
Why?
|
| House Calls | 1 | 2014 | 9 | 0.420 |
Why?
|
| Mass Vaccination | 1 | 2013 | 11 | 0.400 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2013 | 3 | 0.400 |
Why?
|
| Photography | 1 | 2013 | 5 | 0.400 |
Why?
|
| Fundus Oculi | 1 | 2013 | 3 | 0.400 |
Why?
|
| Infant, Newborn | 7 | 2017 | 1479 | 0.400 |
Why?
|
| Sociology, Medical | 1 | 2013 | 2 | 0.400 |
Why?
|
| Incidence | 4 | 2019 | 685 | 0.400 |
Why?
|
| HIV Infections | 4 | 2025 | 5097 | 0.390 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2013 | 27 | 0.390 |
Why?
|
| Health Services Research | 2 | 2010 | 58 | 0.390 |
Why?
|
| Population Density | 1 | 2013 | 13 | 0.390 |
Why?
|
| Health Status Disparities | 1 | 2013 | 35 | 0.390 |
Why?
|
| Disease Susceptibility | 1 | 2013 | 46 | 0.380 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 468 | 0.380 |
Why?
|
| Medication Adherence | 1 | 2014 | 151 | 0.380 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2013 | 33 | 0.380 |
Why?
|
| Pediatric Obesity | 2 | 2023 | 41 | 0.370 |
Why?
|
| Models, Theoretical | 3 | 2019 | 80 | 0.370 |
Why?
|
| Sodium, Dietary | 1 | 2012 | 14 | 0.370 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 1422 | 0.370 |
Why?
|
| Africa | 4 | 2023 | 376 | 0.360 |
Why?
|
| Betacoronavirus | 3 | 2020 | 52 | 0.360 |
Why?
|
| Communicable Disease Control | 3 | 2022 | 101 | 0.350 |
Why?
|
| Income | 4 | 2024 | 85 | 0.350 |
Why?
|
| Immunization | 1 | 2012 | 63 | 0.350 |
Why?
|
| Neurofibromatosis 1 | 5 | 1994 | 5 | 0.350 |
Why?
|
| Maternal Mortality | 3 | 2017 | 58 | 0.350 |
Why?
|
| Retrospective Studies | 5 | 2021 | 799 | 0.340 |
Why?
|
| Fast Foods | 2 | 2021 | 7 | 0.340 |
Why?
|
| Urban Population | 2 | 2024 | 257 | 0.330 |
Why?
|
| Commerce | 2 | 2023 | 22 | 0.330 |
Why?
|
| Energy Intake | 3 | 2021 | 24 | 0.320 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2019 | 262 | 0.320 |
Why?
|
| China | 2 | 2020 | 21 | 0.300 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 237 | 0.300 |
Why?
|
| Peer Review, Research | 1 | 2009 | 2 | 0.300 |
Why?
|
| United States | 6 | 2021 | 132 | 0.290 |
Why?
|
| Quality-Adjusted Life Years | 4 | 2020 | 34 | 0.280 |
Why?
|
| Risk Assessment | 2 | 2013 | 225 | 0.280 |
Why?
|
| Biomedical Technology | 3 | 2022 | 10 | 0.270 |
Why?
|
| Comorbidity | 2 | 2021 | 188 | 0.260 |
Why?
|
| Pregnant Women | 2 | 2024 | 89 | 0.250 |
Why?
|
| Diabetes Complications | 2 | 2019 | 15 | 0.240 |
Why?
|
| Food Handling | 2 | 2023 | 5 | 0.240 |
Why?
|
| Morbidity | 2 | 2017 | 37 | 0.240 |
Why?
|
| Vitamin A | 3 | 2013 | 10 | 0.240 |
Why?
|
| Developed Countries | 2 | 2005 | 24 | 0.240 |
Why?
|
| Administrative Personnel | 2 | 2023 | 17 | 0.230 |
Why?
|
| Sex Factors | 2 | 2017 | 227 | 0.230 |
Why?
|
| Interrupted Time Series Analysis | 1 | 2025 | 21 | 0.220 |
Why?
|
| Genetic Techniques | 2 | 1994 | 9 | 0.210 |
Why?
|
| Dental Atraumatic Restorative Treatment | 1 | 2023 | 2 | 0.210 |
Why?
|
| Surveys and Questionnaires | 6 | 2024 | 563 | 0.210 |
Why?
|
| Dental Caries | 1 | 2023 | 10 | 0.200 |
Why?
|
| Ethics, Research | 1 | 2003 | 6 | 0.200 |
Why?
|
| Environmental Health | 1 | 2003 | 6 | 0.200 |
Why?
|
| Community Participation | 1 | 2023 | 42 | 0.200 |
Why?
|
| Poliovirus Vaccines | 2 | 2013 | 11 | 0.200 |
Why?
|
| Students | 1 | 2023 | 50 | 0.200 |
Why?
|
| Vitamins | 2 | 2013 | 23 | 0.200 |
Why?
|
| Data Collection | 1 | 2023 | 86 | 0.200 |
Why?
|
| Industry | 1 | 2023 | 6 | 0.200 |
Why?
|
| Quality of Life | 1 | 2005 | 177 | 0.200 |
Why?
|
| Malnutrition | 1 | 2022 | 56 | 0.180 |
Why?
|
| Economics, Medical | 1 | 2021 | 2 | 0.180 |
Why?
|
| Decision Making | 2 | 2019 | 53 | 0.180 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 34 | 0.170 |
Why?
|
| Eating | 1 | 2021 | 16 | 0.170 |
Why?
|
| Men | 1 | 2021 | 15 | 0.170 |
Why?
|
| Urbanization | 1 | 2020 | 11 | 0.170 |
Why?
|
| Australia | 1 | 2021 | 48 | 0.170 |
Why?
|
| Africa, Southern | 1 | 2021 | 91 | 0.170 |
Why?
|
| Vegetables | 1 | 2020 | 8 | 0.170 |
Why?
|
| DNA | 4 | 1994 | 73 | 0.160 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 13 | 0.160 |
Why?
|
| Vaccination Coverage | 1 | 2020 | 13 | 0.160 |
Why?
|
| Phenylalanine Hydroxylase | 2 | 1991 | 2 | 0.160 |
Why?
|
| Phenylketonurias | 2 | 1991 | 2 | 0.160 |
Why?
|
| Trust | 1 | 2020 | 9 | 0.160 |
Why?
|
| Feasibility Studies | 1 | 2021 | 101 | 0.160 |
Why?
|
| Drug Implants | 1 | 2019 | 24 | 0.150 |
Why?
|
| Long-Acting Reversible Contraception | 1 | 2019 | 11 | 0.150 |
Why?
|
| Primary Health Care | 4 | 2021 | 240 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2021 | 115 | 0.150 |
Why?
|
| Recommended Dietary Allowances | 1 | 2019 | 11 | 0.150 |
Why?
|
| Influenza Vaccines | 1 | 2020 | 144 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 370 | 0.140 |
Why?
|
| Exercise | 1 | 2020 | 205 | 0.140 |
Why?
|
| Public-Private Sector Partnerships | 2 | 2015 | 17 | 0.140 |
Why?
|
| Prospective Studies | 2 | 2021 | 1160 | 0.140 |
Why?
|
| India | 1 | 2018 | 62 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 18 | 0.140 |
Why?
|
| Needs Assessment | 1 | 2017 | 29 | 0.140 |
Why?
|
| Program Development | 1 | 2017 | 32 | 0.140 |
Why?
|
| Risk Factors | 3 | 2020 | 1475 | 0.130 |
Why?
|
| Body Mass Index | 2 | 2020 | 321 | 0.130 |
Why?
|
| Caffeine | 1 | 2017 | 4 | 0.130 |
Why?
|
| Regression Analysis | 3 | 2013 | 133 | 0.130 |
Why?
|
| Safety | 1 | 2017 | 34 | 0.130 |
Why?
|
| Demography | 2 | 2016 | 105 | 0.130 |
Why?
|
| Influenza, Human | 1 | 2020 | 374 | 0.130 |
Why?
|
| Research Design | 2 | 2009 | 124 | 0.120 |
Why?
|
| Program Evaluation | 1 | 2017 | 89 | 0.120 |
Why?
|
| Family Characteristics | 1 | 2017 | 135 | 0.120 |
Why?
|
| Fees and Charges | 1 | 2016 | 6 | 0.120 |
Why?
|
| Life Tables | 1 | 2016 | 2 | 0.120 |
Why?
|
| Travel | 1 | 2016 | 21 | 0.120 |
Why?
|
| Outpatients | 1 | 2016 | 38 | 0.120 |
Why?
|
| Nutritive Sweeteners | 1 | 2015 | 2 | 0.120 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 17 | 0.120 |
Why?
|
| Teaching | 1 | 2015 | 8 | 0.120 |
Why?
|
| Focus Groups | 3 | 2022 | 196 | 0.120 |
Why?
|
| Rural Health | 1 | 2016 | 118 | 0.120 |
Why?
|
| Government Regulation | 1 | 2015 | 5 | 0.120 |
Why?
|
| Caregivers | 1 | 2016 | 76 | 0.120 |
Why?
|
| Age Factors | 3 | 2015 | 370 | 0.110 |
Why?
|
| Genetics, Medical | 3 | 1994 | 21 | 0.110 |
Why?
|
| Hand Disinfection | 1 | 2015 | 9 | 0.110 |
Why?
|
| Attitude to Health | 1 | 2015 | 56 | 0.110 |
Why?
|
| Water Supply | 1 | 2015 | 10 | 0.110 |
Why?
|
| Body Weight | 1 | 2015 | 111 | 0.110 |
Why?
|
| Survival Rate | 1 | 2015 | 96 | 0.110 |
Why?
|
| Sanitation | 1 | 2015 | 17 | 0.110 |
Why?
|
| Hygiene | 1 | 2015 | 23 | 0.110 |
Why?
|
| Health Education | 1 | 2015 | 35 | 0.110 |
Why?
|
| Labor, Obstetric | 1 | 2015 | 44 | 0.110 |
Why?
|
| Quality of Health Care | 1 | 2015 | 62 | 0.110 |
Why?
|
| Prognosis | 1 | 2015 | 199 | 0.110 |
Why?
|
| NADP Transhydrogenases | 1 | 2014 | 2 | 0.110 |
Why?
|
| Residence Characteristics | 1 | 2015 | 57 | 0.110 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 79 | 0.110 |
Why?
|
| Forecasting | 1 | 2014 | 20 | 0.110 |
Why?
|
| Physicians, Family | 2 | 1993 | 4 | 0.110 |
Why?
|
| Intelligence | 1 | 1994 | 6 | 0.110 |
Why?
|
| Breast Feeding | 1 | 2015 | 120 | 0.110 |
Why?
|
| Public Policy | 2 | 2023 | 24 | 0.110 |
Why?
|
| Information Services | 1 | 1994 | 4 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2014 | 64 | 0.100 |
Why?
|
| Vitamin A Deficiency | 1 | 2013 | 5 | 0.100 |
Why?
|
| Educational Measurement | 1 | 1993 | 3 | 0.100 |
Why?
|
| Psychiatry | 1 | 1993 | 5 | 0.100 |
Why?
|
| Health Services | 2 | 2025 | 51 | 0.100 |
Why?
|
| Health Care Surveys | 1 | 2013 | 30 | 0.100 |
Why?
|
| Linear Models | 1 | 2013 | 83 | 0.100 |
Why?
|
| Educational Status | 2 | 2023 | 68 | 0.100 |
Why?
|
| Helminthiasis | 1 | 2013 | 7 | 0.100 |
Why?
|
| Anthelmintics | 1 | 2013 | 9 | 0.100 |
Why?
|
| Poisson Distribution | 1 | 2013 | 18 | 0.100 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 12 | 0.100 |
Why?
|
| Nevus, Pigmented | 1 | 1992 | 1 | 0.100 |
Why?
|
| Spatial Analysis | 1 | 2013 | 10 | 0.100 |
Why?
|
| Government Programs | 1 | 2013 | 30 | 0.100 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 12 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2013 | 89 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2013 | 55 | 0.100 |
Why?
|
| Age Distribution | 1 | 2013 | 107 | 0.100 |
Why?
|
| Models, Biological | 1 | 2013 | 77 | 0.100 |
Why?
|
| Bayes Theorem | 1 | 2013 | 81 | 0.090 |
Why?
|
| Disease Outbreaks | 1 | 2013 | 111 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2015 | 889 | 0.090 |
Why?
|
| Genetic Markers | 1 | 1992 | 11 | 0.090 |
Why?
|
| Health Status | 1 | 2012 | 111 | 0.090 |
Why?
|
| Mutation | 2 | 1991 | 306 | 0.090 |
Why?
|
| Population Surveillance | 1 | 2013 | 325 | 0.090 |
Why?
|
| Genetic Carrier Screening | 3 | 1996 | 12 | 0.080 |
Why?
|
| Cystic Fibrosis | 3 | 1996 | 9 | 0.080 |
Why?
|
| Health Personnel | 2 | 2022 | 231 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2012 | 317 | 0.080 |
Why?
|
| Feeding Behavior | 2 | 2020 | 60 | 0.080 |
Why?
|
| Turkey | 1 | 2009 | 1 | 0.070 |
Why?
|
| Croatia | 1 | 2009 | 1 | 0.070 |
Why?
|
| Journalism, Medical | 1 | 2009 | 1 | 0.070 |
Why?
|
| PubMed | 1 | 2009 | 1 | 0.070 |
Why?
|
| Mexico | 1 | 2009 | 3 | 0.070 |
Why?
|
| New Zealand | 1 | 2009 | 8 | 0.070 |
Why?
|
| Authorship | 1 | 2009 | 2 | 0.070 |
Why?
|
| Qualitative Research | 2 | 2021 | 321 | 0.070 |
Why?
|
| Public Health Practice | 1 | 2007 | 7 | 0.070 |
Why?
|
| Health Plan Implementation | 1 | 2007 | 16 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2006 | 179 | 0.070 |
Why?
|
| Galactosidases | 1 | 1987 | 1 | 0.060 |
Why?
|
| Galactosylceramidase | 1 | 1987 | 1 | 0.060 |
Why?
|
| Leukodystrophy, Globoid Cell | 1 | 1987 | 1 | 0.060 |
Why?
|
| Retina | 1 | 1987 | 1 | 0.060 |
Why?
|
| Health Behavior | 2 | 2020 | 79 | 0.060 |
Why?
|
| Stereotyping | 1 | 2006 | 5 | 0.060 |
Why?
|
| Communicable Diseases | 1 | 2006 | 62 | 0.060 |
Why?
|
| Accidents, Traffic | 1 | 2005 | 5 | 0.060 |
Why?
|
| Foreign Professional Personnel | 1 | 2004 | 1 | 0.060 |
Why?
|
| Emigration and Immigration | 1 | 2004 | 13 | 0.050 |
Why?
|
| Nutritional Support | 1 | 2024 | 5 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1994 | 37 | 0.050 |
Why?
|
| Brain | 2 | 1994 | 53 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2024 | 85 | 0.050 |
Why?
|
| Burkina Faso | 1 | 2023 | 29 | 0.050 |
Why?
|
| Social Support | 1 | 2024 | 77 | 0.050 |
Why?
|
| Genetic Counseling | 2 | 1994 | 14 | 0.050 |
Why?
|
| Pit and Fissure Sealants | 1 | 2023 | 2 | 0.050 |
Why?
|
| Health Facilities | 1 | 2024 | 40 | 0.050 |
Why?
|
| Analysis of Variance | 2 | 1994 | 64 | 0.050 |
Why?
|
| Ghana | 1 | 2023 | 67 | 0.050 |
Why?
|
| Bioethical Issues | 1 | 2003 | 4 | 0.050 |
Why?
|
| Social Justice | 1 | 2003 | 6 | 0.050 |
Why?
|
| Government | 1 | 2023 | 13 | 0.050 |
Why?
|
| Genetic Testing | 2 | 1994 | 34 | 0.050 |
Why?
|
| Cameroon | 1 | 2022 | 9 | 0.050 |
Why?
|
| Fear | 1 | 2022 | 11 | 0.050 |
Why?
|
| Motivation | 1 | 2023 | 59 | 0.050 |
Why?
|
| Reye Syndrome | 1 | 1982 | 1 | 0.050 |
Why?
|
| Foreign Medical Graduates | 2 | 2009 | 2 | 0.040 |
Why?
|
| Federal Government | 1 | 2021 | 2 | 0.040 |
Why?
|
| Gender Identity | 1 | 2021 | 23 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2020 | 11 | 0.040 |
Why?
|
| Antithrombin III Deficiency | 1 | 1980 | 1 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 39 | 0.040 |
Why?
|
| Family | 1 | 2020 | 35 | 0.040 |
Why?
|
| Micronutrients | 1 | 2020 | 11 | 0.040 |
Why?
|
| Anthropometry | 1 | 2020 | 102 | 0.040 |
Why?
|
| Seasons | 1 | 2020 | 154 | 0.040 |
Why?
|
| Thrombosis | 1 | 1980 | 47 | 0.040 |
Why?
|
| Gene Frequency | 2 | 1991 | 122 | 0.040 |
Why?
|
| Alleles | 2 | 1991 | 143 | 0.040 |
Why?
|
| Haplotypes | 2 | 1991 | 125 | 0.040 |
Why?
|
| Risk Reduction Behavior | 1 | 2019 | 39 | 0.040 |
Why?
|
| Perception | 1 | 2019 | 42 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 1978 | 2 | 0.040 |
Why?
|
| Vaccination | 1 | 2020 | 365 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 203 | 0.040 |
Why?
|
| Pedigree | 2 | 1992 | 30 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 1994 | 22 | 0.030 |
Why?
|
| Physicians | 2 | 1994 | 31 | 0.030 |
Why?
|
| Specialization | 2 | 1993 | 8 | 0.030 |
Why?
|
| Comprehension | 1 | 1996 | 5 | 0.030 |
Why?
|
| United Nations | 1 | 2016 | 12 | 0.030 |
Why?
|
| Attitude of Health Personnel | 2 | 1994 | 106 | 0.030 |
Why?
|
| Dehydrocholesterols | 1 | 1995 | 1 | 0.030 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 1995 | 2 | 0.030 |
Why?
|
| Amniotic Fluid | 1 | 1995 | 13 | 0.030 |
Why?
|
| Cholesterol | 1 | 1995 | 38 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 1994 | 6 | 0.030 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 1994 | 4 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 1994 | 34 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 1994 | 55 | 0.030 |
Why?
|
| Certification | 1 | 1993 | 1 | 0.030 |
Why?
|
| Practice Management, Medical | 1 | 1993 | 1 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 1993 | 3 | 0.030 |
Why?
|
| Phenotype | 1 | 1994 | 158 | 0.030 |
Why?
|
| Diffusion of Innovation | 1 | 1993 | 10 | 0.030 |
Why?
|
| Education, Medical | 1 | 1993 | 7 | 0.030 |
Why?
|
| Curriculum | 1 | 1993 | 27 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 1993 | 43 | 0.020 |
Why?
|
| Foundations | 1 | 2013 | 2 | 0.020 |
Why?
|
| Social Change | 1 | 2013 | 14 | 0.020 |
Why?
|
| Hemangioma | 1 | 1992 | 1 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 1992 | 1 | 0.020 |
Why?
|
| Hemangioendothelioma | 1 | 1992 | 2 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 1992 | 3 | 0.020 |
Why?
|
| Child Welfare | 1 | 2012 | 16 | 0.020 |
Why?
|
| Genes, Neurofibromatosis 1 | 1 | 1992 | 1 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 1992 | 8 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1992 | 22 | 0.020 |
Why?
|
| Life Style | 1 | 2012 | 86 | 0.020 |
Why?
|
| Mediastinal Neoplasms | 1 | 1990 | 2 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1991 | 139 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1990 | 5 | 0.020 |
Why?
|
| Homozygote | 1 | 1991 | 61 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1991 | 263 | 0.020 |
Why?
|
| Gene Amplification | 1 | 1989 | 1 | 0.020 |
Why?
|
| Greece | 1 | 1989 | 2 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1989 | 7 | 0.020 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 1989 | 8 | 0.020 |
Why?
|
| Emigrants and Immigrants | 1 | 2009 | 11 | 0.020 |
Why?
|
| Base Sequence | 1 | 1989 | 149 | 0.020 |
Why?
|
| Electroretinography | 1 | 1987 | 1 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 1987 | 1 | 0.020 |
Why?
|
| Fibroblasts | 1 | 1987 | 14 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 1987 | 79 | 0.020 |
Why?
|
| Health Maintenance Organizations | 2 | 1996 | 4 | 0.010 |
Why?
|
| Baltimore | 2 | 1996 | 5 | 0.010 |
Why?
|
| Research Support as Topic | 1 | 2004 | 6 | 0.010 |
Why?
|
| Odds Ratio | 2 | 1994 | 133 | 0.010 |
Why?
|
| Logistic Models | 2 | 1994 | 254 | 0.010 |
Why?
|
| African Americans | 1 | 1982 | 47 | 0.010 |
Why?
|
| Bone Marrow Diseases | 1 | 1980 | 1 | 0.010 |
Why?
|
| Melphalan | 1 | 1980 | 2 | 0.010 |
Why?
|
| Orthomolecular Therapy | 1 | 1978 | 1 | 0.010 |
Why?
|
| Acne Vulgaris | 1 | 1978 | 4 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 25 | 0.010 |
Why?
|
| Education | 1 | 1996 | 22 | 0.010 |
Why?
|
| Syndrome | 1 | 1995 | 19 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 1994 | 1 | 0.010 |
Why?
|
| Cerebellar Nuclei | 1 | 1994 | 1 | 0.010 |
Why?
|
| Basal Ganglia Diseases | 1 | 1994 | 2 | 0.010 |
Why?
|
| Brain Stem | 1 | 1994 | 5 | 0.010 |
Why?
|
| Uncertainty | 1 | 1994 | 7 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1994 | 45 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1994 | 188 | 0.010 |
Why?
|
| Abortion, Eugenic | 1 | 1993 | 1 | 0.010 |
Why?
|
| Paternalism | 1 | 1993 | 1 | 0.010 |
Why?
|
| Selection Bias | 1 | 1993 | 4 | 0.010 |
Why?
|
| Medicine | 1 | 1993 | 3 | 0.010 |
Why?
|
| Physician's Role | 1 | 1993 | 8 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1993 | 4 | 0.010 |
Why?
|
| Personal Autonomy | 1 | 1993 | 6 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 1993 | 57 | 0.010 |
Why?
|
| Communication | 1 | 1993 | 57 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1990 | 9 | 0.010 |
Why?
|
| Catecholamines | 1 | 1990 | 6 | 0.010 |
Why?
|
| Leukemia | 1 | 1980 | 1 | 0.000 |
Why?
|
| Leukemia, Myeloid | 1 | 1980 | 5 | 0.000 |
Why?
|
| Acute Disease | 1 | 1980 | 105 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 1980 | 62 | 0.000 |
Why?
|